|
Index of reports
> Cases resulting in life threatening events (5)
> Cases with Endometrial Neoplasm (2)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in life threatening events where reactions include endometrial neoplasm.
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-24
Patient: female
Adverse reactions / side effects: Endometrial Neoplasm, Metastases TO Lung
Adverse event resulted in: life threatening event
Suspect drug(s):
Premarin
Dosage: 625ug, frequency unknown
Administration route: Oral
Indication: Uterine Leiomyoma
Start date: 1992-06-01
End date: 1995-01-01
Premarin
Dosage: 125ug, frequency unknown
Administration route: Oral
Indication: Endometriosis
Start date: 1995-01-01
End date: 2004-02-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-18
Patient: female
Adverse reactions / side effects: Endometrial Neoplasm, Metastases TO Lung
Adverse event resulted in: life threatening event
Suspect drug(s):
Premarin
Dosage: 625ug, frequency unknown
Administration route: Oral
Indication: Uterine Leiomyoma
Start date: 1992-06-01
End date: 1995-01-01
Premarin
Dosage: 125ug, frequency unknown
Administration route: Oral
Indication: Endometriosis
Start date: 1995-01-01
End date: 2004-02-01
|
